Pattern of antibiotics resistance and phenotypic characterization of Multidrug resistant bacteria isolates in four hospitals of Littoral region, Cameroon
Objective: To describe the pattern of antibiotics resistance and phenotypic characterization of Multidrug resistant bacteria isolates in four hospitals of Littoral region, Cameroon.
Methods: We conducted a descriptive hospital based cross-sectional study from December 2018 to May 2019. A simple random sampling was used to swap 10 selected equipment and 10 materials in the mornings after disinfection but before the start of work in seven units. After inoculation in four agar media consecutively (Eosine Metyleine blue, Cled, Manitol salt agar and blood agar ) and incubated in appropriate conditions, the Kirby-Bauer disk-diffusion method was used for antimicrobial susceptibility test.
Results: Among 50.4% (119/236) showed positive bacteria growth, a total of 89 (13 species), predominant bacteria and those more likely to cause nosocomial infections were selected and tested each one to 18 antibiotics. There was high level of resistance to Penicillin (amoxicillin (77.5%) and Oxacillin (76.4%)), followed by 3G Cephalosporine (Ceftazidime (74.2%)) and Monobactam (Aztreonam (70.8%)). Although the least level of resistance was observed in Carbapenem (imipenem (5.6%)). The overall prevalence of MDRB was 62.9% (56/89). MRSA were the mostly detected 57.5 % (30/89), followed by ESBL 10.1% (9/89). Military hospital of Douala and Emergency unit was the MDRBs dominantly contaminated area respectively 39.3% (22/56) and 17.9% (10/56).
Conclusion: MDRB occurred to be a current public health problem as well as hospital surfaces are worrying reservoir that can be spread to patient, health professionals and visitors.
Keywords: Antibiotic resistance, susceptibility test, multidrug-resistant bacteria, Hospital facilities, Units, Littoral Region-Cameroon
2. Hortense GK, Etienne G, Michel T, Valantine NN, Calixte DM, Norbert DT et al. Bacteriological assessment of the hospital environment in two referral hospitals in Yaoundé-Cameroon. Pan African Medical Journal 2015; 20:224.
3. Julia L, Vilankar K, Kang H, Brown DE, Mathers A, Barnes LE. Environmental Reservoirs of Nosocomial Infection: Imputation Methods for Linking Clinical and Environmental Microbiological Data to Understand Infection Transmission. AMIA Annu Symp Proc 2017; 2017:1120‑9.
4. Smith, J, Adams CE, King MF, Robertson C, Noakes C, Dancer SJ, Is there a relationship between airborne and surface microbes in the critical care environment. J. Hosp. Infect 2018; 100:e123–e129.
5. Kouchak F, Askarian M. Nosocomial Infections: The Definition Criteria. Iran J Med Sci 2012; 37(2):72-73.
6. Irene O, Daniel NT. Knowledge and attitude of healthcare workers and patients on healthcare associated infections in a regional hospital in Ghana. Asian Pac J Trop Dis 2014; 4(2):135-139
7. Heaven S, NEWSLETER healthline ; What is nosocomial infection , Medically Reviewed by Graham Rogers, MD on 24 October 2016 .Also Available : http://www.healthline.com/health/medical -board. Accessed on 13 December 2017.
8. Ekanga NG, Hortense GK, Albert SE, William B, Godswill NN, Arthur E, et al. Recommendations on the Fight against Nosocomial Infections Compliance In Health Facilities of Yaounde (Cameroon). IJSRM 2019; 7(8):244-255.
9. Adams CE, Dancer S J. Dynamic Transmission of Staphylococcus aureus in the Intensive Care Unit. Int. J. Environ. Res. Public Health 2020; 17: 2109.
10. Soltani J, Poorabbas B, Miri N, Mardaneh J. Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran. World J Clin Cases 2016; 4(3):63‑70.
11. Sievert DM, Ricks P, Edwards JR, Schneider A, Jean P, Srinivasan A Et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the national healthcare safety network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013; 34(1):1-14.
12. Dabar G, Harmouche C, Salameh P, Jaber BL, Jamaleddine G, Waked M Et al. Community-and healthcare-associated infections in critically ill patients: a multicenter cohort study. International Journal of Infectious Diseases 2015; 37:80–85.
13. Kadkhodaei M, Sharif MR, Saba MA, Mousavi GA. Assessing the nosocomial infections' rate and the antibiotic resistance pattern among the patient hospitalized in beheshti hospital during 2013. Int Arch Health Sci 2018; 5:11-5.
14. WHO Healthcare-Associated infections, fact scheet, 2014, WHO, The Burden of Healthcare-Associated infections worldwide: Summary, 2010, and CDC, Vital Signs Report, March 2016.
15. Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations. Available From https://www.sciencedirect.com/science/article/abs/pii/S0883944117308365. Accessed 22 July 2020.
16. Feleke T, Eshetie S, Dagnew M, Endris M, Abebe W, Tiruneh M, et al. Multidrug-resistant bacterial isolates from patients suspected of nosocomial infections at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. BMC Res Notes 2018; 11(1):602.
17. Makanjuola OB, Fayemiwo SA, Okesola AO, Gbaja A , Ogunleye VA, Kehinde AO et al. Pattern of multidrug resistant bacteria associated with intensive care unit infections in Ibadan, Nigeria. Ann Ibd. Pg. Med 2018; 16(2):162-169
18. Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. 2014.
19. Donkor SE, Codjoe FS. Methicillin Resistant Staphylococcus aureus and Extended Spectrum Beta-lactamase Producing Enterobacteriaceae: A Therapeutic Challenge in the 21stCentury. The Open Microbiology Journal 2019; 13:94-100.
20. CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services, CDC; 2019.
21. Garba I, Farouq MD, Salisu A, Salisu I , Sirajo HT, Abdulwasiu BT et al.. Laboratory-confirmed hospital-acquired infections: An analysis of a hospital’s surveillance data in Nigeria. Heliyon2018; 4: e00720. https://doi:10.1016/j.heliyon.2018.e0072.
22. Citation: McEwen S, Collignon P. Antimicrobial Resistance: a One Health Perspective. Microbiol Spectrum 2018; 6(2): ARBA-0009-2017.doi: 10.1128/microbiolspec.ARBA-0009-2017.
23. White A, Hughes MJ. Critical Importance of a One Health Approach to Antimicrobial Resistance. EcoHealth 2019; 16:404–409. https://doi.org/10.1007/s10393-019-01415-5.
24. Olutola OT, Adeyanju A, Torimiro N. Extended Spectrum β-lactamase Detection and Antibiotic Susceptibility Profile of Staphylococcus aureus Strains Isolated from Surgical Wound. British Microbiology Research Journal 2016; 17(5):1-7.
25. Ministère de la santé publique. Guide de Bonnes Pratiques d'hygiène en milieu hospitalier. Yaoundé 2017.
26. Cheesbrough M. District laboratory practice in tropical countries. New York: Cambridge University Press; 2006.
27. Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Susceptibility Testing, Vol. 35, CLSI, Wayne, PA, USA, 2017.
28. Okalla-Ebongue C, Nkodo MR, Nda-Mefo JP, Temfack E, Mengue ER, Adiogo D. Phenotypic Detection of Extended SpectrumβLactamase and AmpC producing Enterobacteriaceae Isolated in A General Hospital. J Microbiol Infect Dis2018; 8(3):113-119.
29. Laboratory detection and reporting of bacteria with extended spectrum βLactamases. Standard Unit, Evaluation and standard laboratory2019; (2) 2: 1-13.
30. CDC ESBL 508. Available from https://www.cdc.gov/drugresistance/pdf/threats-report/esbl-508.pdf .Accessed on 22 Jul. 2020.
31. Dancer SJ. Importance of the environment in MRSA acquisition: The case for hospital cleaning. Lancet Infect.Dis 2008; 8: 101–113. [CrossRef]
32. Coll F, Harrison EM, Toleman MS, Reuter S, Raven E, Blane B. Longitudinal genomic surveillance of MRSA in the UK reveals transmission patterns in hospitals and the community. Sci. Transl. Med2017; 9:413. [CrossRef]
33. Hoseini Z A, Shojapour M, Nazari R, Akbari M, Sofian M, Abtahi H. Genotyping of vancomycin resistant enterococci in arak hospitals. Jundishapur J Microbiol 2015; 8(4):e16287.
34. Ferede ZT, Tullu KD, Derese SG, Yeshanew AG. Prevalence and antimicrobial susceptibility pattern of Enterococcus speciesisolated from different clinical samples at Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia. BMC Res Notes2018; 11(1):793.
35. Feleke T, Eshetie S, Dagnew M, Endris M, Abebe W, Tiruneh M, et al. Multidrug-resistant bacterial isolates from patients suspected of nosocomial infections at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. BMC Res Notes 2018; 11(1):602.
36. Cornejo-Juarez P, Vilar-Compte D , Pe´rez-Jime´nez C, N˜amendys-Silva SA, S, Sandoval-Hernandez S ,Volkow-Fernandez P .The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. International Journal of Infectious Diseases 2015; 31: 31–34
37. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect2012; 18(3):268-281.
38. Ebimieowei E, Ibemologi A. Antibiotics: Classification and mechanisms of action with emphasis on molecular perspectives. Int. J. Appl. Microbiol. Biotechnol. Res2016; 4:90-101.
39. Ye L, Zhenyu G, Ye L, Guoqing H, Ran C, Zhiping C. Impact of nosocomial infections surveillance on nosocomial infection rates : A systematic review. International Journal of Surgery2017; 42:164-169. http://dx.doi.org/10.1016/j.ijsu.2017.04.065.
40. Chun'ai T, Yongxin G, Weidong S, Zhutian L, Xiaolan T. Effectiveness of hospital disinfection and experience learnt from 11 years of surveillance. J Biomed Res 2019; 33:408–413. https://doi.org/10.7555/JBR.33.20180118.
41. Mohamed MMM, Frédéric M, Jene-Francis TKA, Ndode HON , Nabilah PM, Valentine NN et al. Antimicrobial resistance from a one health perspective in Cameroon: a systematic review and meta-analysis. BMC Public Health 2019; 19:1135. https://doi.org/10.1186/s12889-019-7450-5.
42. CDC, the AMR challenge, 2019. Available from : https://www.cdc.gov/drugresistance/intl-activities/amr-challenge.html. Accessed 31/07/20.
43. Costa DM, Johani K, Melo DS, Lopes LKO, Lima LLKO, Tipple AFV et al.. Biofilm contamination of high-touched surfaces in intensive care units: epidemiology and potential impacts. Letters in Applied Microbiolog 2019; 68:269-276. https://doi.org/10.1111/lam.13127.
44. Worku T, Derseh D, Kumalo A. Bacterial Profile and Antimicrobial Susceptibility Pattern of the Isolates from Stethoscope, Thermometer, and Inanimate Surfaces of Mizan-Tepi University Teaching Hospital , Southwest Ethiopia. Int J Microbiol 2018; 2018:1-7. https://doi.org/10.1155/2018/9824251.
45. Kwetché FPR, Kougang EG,Noche DC, Youté DN, Tchoukoua HS, Djogang YMA et al. Mitigating hospital infection risks at the “université des montagnes” teaching hospital: holistic policy to Meet the challenge. WJPPS 2020; 9(3):518-535. https://doi.org/10.20959/wjpps20203-15708.
46. Bhatta DR, Hamal D, Shrestha R, Subramanya HS, Baral N, Singh RK, Nayak N and Gokhale S. (2018) Bacterial contamination of frequently touched objects in a tertiary care hospital of Pokhara, Nepal: how safe are our hands? Antimicrob Resist Infect Control. BioMed Central 2018; 7:97. https://doi.org/10.1186/s13756-018-0385-2.
47. Aseer et al. Magnitude, diversity, and antibiogram of bacteria isolated from the selected wards of Arba Minch hospital, Arba Minch, Ethiopia 2020. https://doi.org/10.21203/rs.2.23933/v1. Available from https://www.researchsquare.com/article/rs-14494/v1. Accessed 4/08/2020.
48. Ndu IK, Asinobi NI, Ekwochi U, Nduagubam CO, Amadi OF, Okeke BI, Iheji CC, et al.. The bacterial profile and antibiotic sensitivity of the isolated pathogens from medical equipment and surfaces in the children’s emergency room of a Nigerian hospital. Medical Science and Discovery 2019 6(9):192-7. http://dx.doi.org/10.36472/msd.v6i9.291.
49. Afle DCF, Alidéhou J A, Roch C J, Olivia H, Sègbè C H, Honoré S B. Healthcare-associated infections: bacteriological characterization of the hospital surfaces in the University Hospital of Abomey-Calavi/so-ava in South Benin (West Africa). BMC Infectious Diseases 2019; 19:28.https://doi.org/10.1186/s12879-018-3648-x.
50. Hearn P, MiliyaT, Seng S, Ngoun C, Day NPJ., Lubell Y, Turner C Et al. Prospective surveillance of healthcare associated infections in a Cambodian pediatric hospital. Antimicrobial Resistance and Infection Control 2017; 6:16. https://doi.org/10.1186/s13756-017-0172-5.
51. Saka KH, Akanbi II AA, Obasa TO, Raheem RA, Oshodi AJ, et al. Pathogenic Aerobic Bacterial Contaminants on Non-Critical Hospital Surfaces within Paediatric Ward of a Nigerian Hospital. J Med Microb Diagn 2016; 5:241.
52. Suleyman G, Alangaden G,Bardossy CA.The Role of Environmental Contamination in the Transmissionof Nosocomial Pathogens and Healthcare-Associated Infections. Current Infectious Disease Reports 2018; 20:12.https://doi.org/10.1007/s11908-018-0620-2.
53. Agaba P, Tumukunde P, Tindimwebwa VBJ, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes 2017; 10:349.
54. Nouri F, Karami P, Zarei O, Kosari F, Alikhani YM, Zandkarimi E et al..Prevalence of Common Nosocomial Infections and Evaluation of Antibiotic Resistance Patterns in Patients with Secondary Infections in Hamadan, Iran. Infection and Drug Resistance 2020; 13:2365–2374. https://doi.org/10.2147/IDR.S259252.
55. Gajdács M, Albericio F.Antibiotic Resistance: From the Bench to Patients. Antibiotics 2019; 8: 129 .https://doi.org/doi:10.3390/antibiotics8030129.
56. Atrouni A, Joly-Guillou ML, Hamze M, Kempf M.Reservoirs of Non-baumannii Acinetobacter Species. Front. Microbiol 20167:49. https://doi.org/10.3389/fmicb.2016.00049.
57. Takemegni WJM, Assob NJC, Ateudjieu J, Enow OG, Ngowe NM. (2020) Major Bacteria Species Surface Contaminants in Hospitals of Littoral Region, Cameroon. European Journal of Clinical and Biomedical Sciences 2020; 6(3):26-34.
58. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 2010; 38(5):S25–S33.
59. Hübner NO, Hübner C, Kramer A, Assadian O. Survival of bacterial pathogens on paper and bacterial retrieval from paper to hands: preliminary results. AmJ Nurs 2011; 111(12):30-34.
60. Otter JA, Yezli S, Salkeld JA, French GL, Path FRC.Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control 2013; 41: S6–S11.
61. Shimose LA, Masuda E, Sfeir M, Berbel Caban A, Bueno MX, dePascale D et al. Carbapenem-resistant Acinetobacter baumannii: concomitant contamination of air and environmental surfaces. Infect Control Hosp Epidemiol 2016; 37(7):P777–781.
62. Canadian Nosocomial Infection Surveillance Program. Healthcare-associated infections andantimicrobial resistance in Canadian acute care hospitals, 2014–2018. Can Commun Dis 2020; 46(5):99–112.https://doi.org/10.14745/ccdr.v46i05a01.
63. ChelliAh A, Ravinder T , Katragadda R, leelA KV, Babu NR. Isolation of MRSA, ESBL and AmpC – β-lactamases from Neonatal Sepsis at a Tertiary Care Hospital. Journal of Clinical and Diagnostic Research 2014; 8(6):DC24-DC27. https://doi.org/10.7860/JCDR/2014/8597.4512.
64. Chaoui L, RajaaAit M, Fouad M, Naima R. Contamination of the Surfaces of a Health Care Environment by Multidrug-Resistant (MDR) Bacteria. International Journal of Microbiology 2019; 2019:7. https://doi.org/10.1155/2019/3236526.
65. Thean Y T, Jasmine SM T, Huiyi T, Gek H C, Lily SY,Nur S. Multidrug-resistant organisms in a routine ward environment: differential propensity for environmental dissemination and implications for infection control. Journal of Medical Microbiology 2013; 62:766–772.https://doi.org/10.1099/jmm.0.052860-0.
66. Teghonong J, Cecile OE, Callixte Y, Loick K, Dieudonne A. Phenotypic Characteristics of Klebsiella pneumoniae Extended Spectrum β-Lactamases Producers Isolated in Hospitals in the Littoral Region, Cameroon. European Journal of Clinical and Biomedical Sciences 2020 6(1):9-13.https://doi.org /10.11648/j.ejcbs.20200601.13.
67. Rupp ME, Fey PD. ESBL-producing Enterobacteriaceae considerations for diagnosis, prevention and drug treatment. Drugs2003; 63(4):353-365.
68. Hawkey PM. Molecular epidemiology of clinically significant antibiotic resistance genes. British Journal of Pharmacology 2008; 153: S406–S413.
69. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284:1318- 1322.
70. Mesrati I, Saidani M, Jemili M, Ferjeni S, Slim A, Boubaker IBB. Virulence determinants, biofilm production and antimicrobial susceptibility in Staphylococcus aureus causing device-associated infections in a Tunisian hospital. Int J Antimicrob Agents. déc 2018; 52(6):922‑9. https://doi.org/10.1016/j.ijantimicag.2018.05.004.
71. Saxena S, Priyadarshi M, Saxena A, Singh R. Antimicrobial consumption and bacterial resistance pattern in patients admitted in I.C.U at a tertiary care center. J Infect Public Health 2019; 12(5):695‑699. https://doi.org/10.1016/j.jiph.2019.03.014.
72. Soltani J, Poorabbas B, Miri N, Mardaneh J. Health care associated infections, antibiotic resistance and clinical outcome: A surveillance study from Sanandaj, Iran. World J Clin Cases 2016; 4(3):63‑70. https://doi.org/10.12998/wjcc.v4.i3.63.
73. Agegne M, Abera B, Derbie A, Yismaw G, Shiferaw MB. Magnitude of Vancomycin-Resistant Enterococci (VRE) Colonization among HIV-Infected Patients Attending ART Clinic in West Amhara Government Hospitals. Int J Microbiol 2018; 2018:7. https://doi.org/10.1155/2018/7510157.
74. Murni IK, Duke T, Kinney S, Daley AJ, Soenarto Y. Reducing hospital-acquired infections and improvingthe rational use of antibiotics in a developingcountry: an effectiveness study Arch Dis Child 2014; 0:1-6. https://dx.doi.org/10.1136/archdischild-2014-307297.
75. Action on Antibiotic Resistance (ReAct) Africa Annual Conference. (2017) Report. 23.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).